Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Algernon Pharmaceuticals Inc. AGNPF


Primary Symbol: C.AGN

Algernon Pharmaceuticals is a clinical stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough. The company's business model is highly capital efficient and strives to deliver maximum shareholder value. Algernon's unique approach to drug discovery is based on the concept of drug repurposing.


Company Profile & Information (OTCQB:AGNPF)

Showcase News Releases

Showcase news

Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares for Debt
Tocvan Ventures Corp
Tocvan Announces Private Placement with Strategic Investors
Personas Social Incorporated
Personas Provides Update to Clarify Certain Disclosure in Various Previously Filed Financial Statements and MD&A

More Showcase News Releases »